Ratnakar Securities Pvt. Ltd.

SENORES PHARMACEUTICALS LTD.

NSE : SENORESBSE : 544319ISIN CODE : INE0RB801010Industry : Pharmaceuticals & DrugsHouse : Private

BSE765.80-11.6 (-1.49 %)

PREV CLOSE ( ) 777.40

OPEN PRICE ( ) 778.85

BID PRICE (QTY) 765.30 (8)

OFFER PRICE (QTY) 766.65 (37)

VOLUME 1272

TODAY'S LOW / HIGH ( )765.35 782.15

52 WK LOW / HIGH ( )440 832

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 2017

Management Info

Sanjay Shaileshbhai Majmudar - Chairman Swapnil Jatinbhai Shah - Managing Director

Registered Office

Address 1101 To 1103, 11th Floor, South Tower,One 42 Opp. Jayantilal Park,Ambali Bopal Road,
Ahmedabad,
Gujarat-380054

Phone 079-29999857

Email info@senorespharma.com

Website www.senorespharma.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

05Dec Senores Pharmaceuticals informs about
Senores Pharmaceuticals has informed that the exchange has received Disc..

05Dec Senores Pharmaceuticals gets marketing
Senores Pharmaceuticals has received marketing authorizations from the P..

07Nov Senores Pharmaceuticals informs about
Senores Pharmaceuticals has informed that pursuant to Regulation 30 and..

08Oct Senores Pharmaceuticals informs about
Senores Pharmaceuticals has enclosed a certificate, pursuant to Regulati..

13Aug Senores Pharmaceuticals signs agreemen
Senores Pharmaceuticals through its wholly-owned subsidiary -- Senores P..

Financials

in Millions

	QTR Sep 25	ANNUAL 25
Net Profit	64.3	36.9
Gross Profit	76.6	51.1
Operating Profit	128.9	147.1
Net Sales	353.3	385.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE) 2689.75 (1.93%)	M.Cap ( in Cr)33334.70
Mercury Laboratories (BSE) 917.00 (4.35%)	M.Cap ( in Cr)105.46
Venus Remedies (BSE) 765.00 (2.66%)	M.Cap ( in Cr)1001.19
Trident Lifeline (BSE) 320.00 (5.54%)	M.Cap ( in Cr)374.33
Starsource Multitrad (BSE) 125.00 (12.21%)	M.Cap ( in Cr)16.71

Shareholding Pattern

	PROMOTERS	45.8%
	NON-INSTITUTION	41.31%
	MUTUAL FUNDS/UTI	3.54%
	FI/BANKS/INSURANCE	2.95%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Mahindra Manulife L...	1.73
Bank of India Multi...	0.87
Mahindra Manulife B...	0.81
ICICI Pru Pharma He...	0.71
Bank of India Mid &...	0.54
Bandhan BSE Healthc...	0.14

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

SENORES PHARMACEUTICALS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES